Instituto Catalan de Oncologia - ICO ( Site 0044)

Barcelona 08916

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Pharmacokinetics, Solid Tumor, Triple Negative Breast Neoplasms

Studies at this site

• Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001) — Completed